Over the years, various groups have extensively worked towards the identification of specific small-molecule inhibitors able to target the DNA repair function of APE1 in combination studies, with the rationale that the blockade of APE1 endonuclease activity might have various therapeutic applications, particularly in cancer treatment, by sensitizing cancer cells to DNA-damaging agents and leading to tumor cell death. This evidence concerns the gene APEX1 and cancer.